Lifestyle
GLP-1 treatment extends the lifespan of older, healthy mice
Advertisement
Abstract editorial illustration for: GLP-1 treatment extends the lifespan of older, healthy mice
AI Generated
Advertisement
A UC Berkeley-led study finds GLP-1 receptor agonists, drugs used for metabolic disorders, increased lifespan in older healthy mice. The results hint these treatments may act on fundamental aging biology, not just metabolic disease. Readers interested in aging therapies, drug repurposing, and potential human impacts will want the study details.
Source: UC Berkeley News
Related coverage
Business
Watch: the history of capitalism, explained in 101 seconds
News
How tiny balls of human brain tissue are revealing the causes of childhood epilepsy — and possible treatments
News
Desert soils pull in carbon dioxide at night, Berkeley researchers find
News
Agency says sea turtle eggs laid on California beaches are a first for the US West Coast
News
The ancient ancestor of CRISPR is a unique and potentially powerful genomic tool
Business
UC Berkeley again ranked top public university by U.S. News & World Report
Business
Paramount Skydance settles Democrats
Politics